59 min ago
Paractin Featured in New Medical Book
ParactinA , a signature nutraceutical ingredient from Herbal Powers Corp. DBA HP Ingredients.
Thu May 23, 2013
Understanding sulfa drugs' side effects
Researchers in Switzerland have discovered how sulfonamide drugs - the first antimicrobial drugs to be discovered in the 1930s - cause the neurological side effects that sometimes occur following treatment.
[Research Articles] Erosive Rheumatoid Arthritis Is Associated with...
Peptidylarginine deiminases play a critical role in generating autoantigens in rheumatoid arthritis , but the mechanisms underlying their dysregulation in this disease remain unknown.
Abbott Labs Ordered to Pay $2.2M for Risky Arthritis Drug
A jury has ordered the maker of the popular arthritis drug Humira to pay $2.24 million for not warning doctors about a life-threatening side effect.
Wed May 22, 2013
Protalex, Inc. Reports Positive Interim Review of Phase 1b Trial of...
Protalex, Inc. Reports Positive Interim Review of Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis by Independent Data Safety Monitoring Committee Staying up-to-date has never been simpler.
Insurance Journal West
U.S. Spending on Specialty Medications Will Rise 67%: Report
Spending in the U.S. on specialty drugs used to treat serious diseases is projected to increase 67 percent by the end of 2015, according to a forecast by pharmacy benefit management firm Express Scripts.
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe cases of the disease, the immune system makes a unique subset of antibodies that have a disease-promoting role.
Google Co-Founder's Latest Medical Condition Could Be Tied to Autoimmunity
Detroit - May 21, 2013 - Larry Page, co-founder of Google, recently announced he is suffering from paralyzed vocal cords.
Tue May 21, 2013
Express Scripts: Spending on specialty medications to grow 67 percent
Express Scripts expects spending on specialty medications in the U.S. to jump 67 percent by the end of 2015, according to a new company study released Tuesday.
Study shows COPD is associated with significant and persistent pain
ATS 2013, PHILADELPHIA - Chronic obstructive pulmonary disease is primarily associated with the respiratory symptoms that are its hallmark, but in fact, patients who struggle with the disease also experience significant amounts of chronic pain.
US Food and Drug Administration
Sandoz US Announces Voluntary Nationwide Recall of two lots of...
May 20, 2013 - Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer.
Sun May 19, 2013
The Press On-Line
'Leapstars' getting off that couch
Arriving at Melton Estate for the 2013 RISE women in business forum in Christchurch last week, one can hear from the carpark the sound of laughter and clapping.
Arthritis Drug Simponi (Golimumab) Gets Expanded Indication for Ulcerative Colitis
The FDA has approved a new use for Simponi injection to treat adults with moderate-to-severe ulcerative colitis.
Sat May 18, 2013
New York Daily News
Daily Checkup: Advances in arthritis research
' height='423' itemprop='associatedMedia' alt='' width='635' src='http://assets.nydailynews.com/polopoly_fs/1.1343711.1368556801!/img/httpImage/image.jpg_gen/derivatives/landscape_635/checkup19f-1-web.jpg' /> THE SPECIALIST: The acting chief of rheumatology at Mount Sinai, Dr.
A plant-based diet: 9 fruits and vegetables to help battle arthritis pain
Suffers of rheumatoid arthritis may find some relief by incorporating more plant-based foods and less meat and dairy products.
Moving forward in rheumatoid arthritis
May 17th 2013 - Edison Investment Research today published a report on Neovacs entitled "Moving Forward In Rheumatoid Arthritis". In summary, the report says: Neovacs intends to initiate a Phase IIb trial with its lead product TNFI -Kinoid in rheumatoid arthritis .
Fri May 17, 2013
Applied Clinical Trials
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 /PRNewswire/ -- ... (more)
Thu May 16, 2013
Antares: Reiteration Of My Buy Recommendation
It has been some time since I have written on Antares ; in fact, my last note was in September 2012.
The Motley Fool
Sanofi and Regeneron's Latest Partnership
This antibody is being tested in combination with methotrexate, a drug often used for the treatment of rheumatoid arthritis, and will be compared to Amgen Enbrel.
Wed May 15, 2013
Endothelial Dysfunction in Rheumatoid Arthritis: The Role of Monocyte ...
From the Department of Cardiovascular Medicine , and the Department of Rheumatology , First Affiliated Hospital of Medical School, Cardiovascular Research Center , and Key Laboratory of Environment and Genes Related to Diseases , Medical School, Xi'an Jiaotong University, Xi'an, China; and Division of Biomedical Sciences, University of California, ... (more)